4//SEC Filing
CHALMERS DEREK T 4
Accession 0001209191-21-054300
CIK 0001346830other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 6:04 PM ET
Size
5.2 KB
Accession
0001209191-21-054300
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2021-08-30$14.20/sh−8,440$119,848→ 1,011,405 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001166287
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 6:04 PM ET
- Size
- 5.2 KB